Lonza L7 hiPSC Reprogramming and hPSC Culture System

Friday, 27 June, 2014 | Supplied by: Lonza Australia Pty Ltd



Lonza introduces its L7 hiPSC Reprogramming and hPSC Culture System for basic stem-cell research, disease modelling, drug development and regenerative medicine. The offering includes tools to simplify and streamline the stem-cell culturing and reprogramming workflow. The culture system supports the generation of reproducible, clinically relevant data as a solid basis for more efficient drug development and accelerated progress in regenerative medicine.

The stem-cell reprogramming and culture system includes seven key components that are aligned and function as a robust workflow: primary cells, including disease phentoypes; Nucleofector technology; hPSC reprogramming kits; hPSC medium; hPSC matrix; hPC passaging solution; hPSC cryosolution.

The culture system is claimed to be the only complete solution for the generation of induced pluripotent stem-cells (iPSCs), the maintenance of human embryonic stem-cells (hESCs) and iPSCs under defined, xeno-free conditions. It allows for every other day feeding and supports long-term culture and maintenance of hPSCs. The system thus provides a seamless transition from the lab bench to clinical development applications.

Online: www.lonza.com
Phone: 03 9550 0883
Related Products

BioGX Xfree COVID-19 Direct RT-PCR test

The Xfree COVID-19 Direct RT-PCR test is a complete test in a single vial, lyophilised...

Bio-Rad Laboratories CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems

Bio-Rad Laboratories' CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems are suitable for...

PCR Biosystems NGSBIO Library Quant Kit for Illumina

The kit contains all the components necessary for sensitive quantification of DNA libraries prior...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd